Analysis Of Income And Expense [Abstract]

Fresenius Medical Care AG & Co. KGaA - Filing #6524128

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue from sale of goods
4.059.681 EUR
3.979.948 EUR
3.742.403 EUR
Revenue from rendering of services
15.393.936 EUR
15.418.069 EUR
13.876.282 EUR
Revenue
19.453.617 EUR
19.398.017 EUR
17.618.685 EUR
Material income and expense [abstract]
Research and development expense
231,970 EUR
228,624 EUR
220,782 EUR
Selling, general and administrative expense [abstract]
Selling, general and administrative expense
3.196.336 EUR
3.170.370 EUR
2.772.831 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
607,873 EUR
5,086 EUR
564,434 EUR
43,439 EUR
558,371 EUR
11,094 EUR
55,000 EUR
826,847 EUR
59,299 EUR
723,000 EUR
3,036 EUR
767,548 EUR
10,061 EUR
775,296 EUR
89,863 EUR
634,000 EUR
944,376 EUR
3,145 EUR
12,342 EUR
954,207 EUR
1.034.239 EUR
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations
607,873 EUR
826,847 EUR
1.034.239 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates and joint ventures accounted for using equity method
121,785 EUR
66,559 EUR
92,175 EUR
Share of other comprehensive income of associates and joint ventures accounted for using equity method, before tax [abstract]
Share of other comprehensive income of associates and joint ventures accounted for using equity method that will not be reclassified to profit or loss, before tax
EUR
22,705 EUR
25,334 EUR
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss
16,196 EUR
94,294 EUR
4,085 EUR
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss
254,000 EUR
4,849 EUR
1,889 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
102,447 EUR
87,575 EUR
190,022 EUR
1.943.327 EUR
280,219 EUR
1.663.108 EUR
339,583 EUR
1.896.959 EUR
2.236.542 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
87,575 EUR
1.663.108 EUR
1.896.959 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
190,022 EUR
280,219 EUR
339,583 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.